Accéder au contenu
Merck

N-phthaloyl-glycine-hydroxamic acid as serum iron chelator in rats.

Acta pharmaceutica (Zagreb, Croatia) (2008-06-03)
Julija Matijević-Sosa, Ita Samarzija, Lorena Honović, Blazenka Jurisić
RÉSUMÉ

The aim of this study was to investigate the activity of N-phthaloyl-glycine-hydroxamic acid (Phth-Gly-HA) as a new iron chelator in vivo to be used in iron overload diseases. After intraperitoneal application of Phth-Gly-HA to male rats (1 mg kg(-1) body mass) once a day for seven days, iron serum level decreased by 21%, whereas the iron value dropped by 32% in female rats (1.5 mg kg(-1) body mass). The results indicate that the tested substance has the ability to bind serum iron by complexation. Besides transferrin iron release, mobilization of ferritin iron is also possible.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
N-Phthaloylglycine, 97%